Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cellular membrane composition defines A beta-lipid interactions.

S A Waschuk1, E A Elton, A A Darabie

  • 1Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario M5S 3H2, Canada.

The Journal of Biological Chemistry
|July 5, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory.

Scientific reports·2016
Same author

Islet amyloid inhibitors improve glucose homeostasis in a transgenic mouse model of type 2 diabetes.

Diabetes, obesity & metabolism·2015
Same author

Amyloid formation in human islets is enhanced by heparin and inhibited by heparinase.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways.

Molecular and cellular neurosciences·2015
Same author

Altered brain development in an early-onset murine model of Alzheimer's disease.

Neurobiology of aging·2014
Same author

Proliferation, differentiation and amyloid-β production in neural progenitor cells isolated from TgCRND8 mice.

Neuroscience·2013

Alzheimer's disease involves amyloid-beta (A beta) aggregation. Brain membrane composition influences A beta aggregation, with plasma and endosomal membranes accelerating it, while Golgi membranes stabilize A beta.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Cell Biology

Background:

  • Alzheimer's disease (AD) pathology is linked to amyloid-beta (A beta) aggregation.
  • A beta accumulation occurs in specific cellular compartments, suggesting a role for lipid composition.
  • Understanding A beta-lipid interactions is crucial for AD research.

Purpose of the Study:

  • To investigate the role of different human brain membrane lipid compositions in A beta aggregation.
  • To determine how A beta 40/42 interacts with plasma, endosomal, lysosomal, and Golgi membranes.

Main Methods:

  • Isolation of human brain plasma, endosomal, lysosomal, and Golgi membranes using sucrose gradients.
  • Assessment of A beta fibrillogenesis using electron microscopy.
  • Analysis of lipid properties and A beta-lipid interactions via fluorescence spectroscopy with environment-sensitive probes.

Related Experiment Videos

Main Results:

  • A beta fibrillogenesis was accelerated by plasma, endosomal, and lysosomal membranes, with plasma membranes promoting enhanced surface organization.
  • A beta interaction with Golgi membranes did not lead to fibril formation, indicating stabilization.
  • A beta 40/42 binding decreased fluidity in plasma, endosomal, and lysosomal membranes, suggesting bilayer insertion.
  • A beta 40/42 binding increased Golgi membrane fluidity, attributed to head group interactions and packing defects.

Conclusions:

  • Brain membrane lipid composition significantly influences amyloid-beta aggregation pathways in Alzheimer's disease.
  • Plasma and endosomal membranes promote A beta aggregation, whereas Golgi membranes appear to stabilize A beta.
  • Differential A beta-lipid interactions within cellular compartments may offer therapeutic targets for Alzheimer's disease.